CLIP170 inhibits the metastasis and EMT of papillary thyroid cancer through the TGF-β pathway

Metastasis poses a significant challenge in combating tumors. Even in papillary thyroid cancer (PTC), which typically exhibits a favorable prognosis, high recurrence rates are attributed to metastasis. Cytoplasmic linker protein 170 (CLIP170) functions as a classical microtubule plus-end tracking pr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Medical oncology (Northwood, London, England) London, England), 2024-05, Vol.41 (6), p.137, Article 137
Hauptverfasser: Ma, Binyuan, Xu, Yaxin, Gao, Hongwei, Yang, Yinggui, Pan, Yunyan, You, Chongge
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 6
container_start_page 137
container_title Medical oncology (Northwood, London, England)
container_volume 41
creator Ma, Binyuan
Xu, Yaxin
Gao, Hongwei
Yang, Yinggui
Pan, Yunyan
You, Chongge
description Metastasis poses a significant challenge in combating tumors. Even in papillary thyroid cancer (PTC), which typically exhibits a favorable prognosis, high recurrence rates are attributed to metastasis. Cytoplasmic linker protein 170 (CLIP170) functions as a classical microtubule plus-end tracking protein (+TIP) and has shown close association with cell migration. Nevertheless, the specific impact of CLIP170 on PTC cells remains to be elucidated. Our analysis of the GEO and TCGA databases unveiled an association between CLIP170 and the progression of PTC. To explore the impact of CLIP170 on PTC cells, we conducted various assays. We evaluated its effects through CCK-8, wound healing assay, and transwell assay after knocking down CLIP170. Additionally, the influence of CLIP170 on the cellular actin structure was examined via immunofluorescence; we further investigated the molecular expressions of epithelial-mesenchymal transition (EMT) and the transforming growth factor-β (TGF-β) signaling pathways through Western blotting and RT-qPCR. These findings were substantiated through an in vivo nude mouse model of lung metastasis. We observed a decreased expression of CLIP170 in PTC in contrast to normal thyroid tissue. Functionally, the knockdown of CLIP170 (CLIP170 KD ) notably enhanced the metastatic potential and EMT of PTC cells, both in vitro and in vivo. Mechanistically, CLIP170 KD triggered the activation of the TGF-β pathway, subsequently promoting tumor cell migration, invasion, and EMT. Remarkably, the TGF-β inhibitor LY2157299 effectively countered TGF-β activity and significantly reversed tumor metastasis and EMT induced by CLIP170 knockdown. In summary, these findings collectively propose CLIP170 as a promising therapeutic target to mitigate metastatic tendencies in PTC.
doi_str_mv 10.1007/s12032-024-02355-z
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3051425446</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3051425446</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-83ddda9c4b9e340f43ca6d8893482ade681bf950f6c7ae165a4e0ead6006d1423</originalsourceid><addsrcrecordid>eNp9kMtKAzEUhoMotlZfwIUMuHEzenKby1JKWwsVXVRwZchMMp0p7UxNZpD2sXwQn8m0Uy-4EHJIDvn-Pyc_QucYrjFAeGMxAUp8IMwV5dzfHKAu5jz2McXPh7_OHXRi7RyAYE7iY9ShUQg8prSLXvqT8SMOwSvKvEiK2np1rr2lrqV1q7CeLJU3uJ96Veat5KpYLKRZO2ZtqkJ5qSxTbVxrqmaW76TT0dD_eHdsnb_J9Sk6yuTC6rP93kNPw8G0f-dPHkbj_u3ETykJaj-iSikZpyyJNWWQMZrKQEVRTFlEpNJBhJMs5pAFaSg1DrhkGrRUAUCgMCO0h65a35WpXhtta7EsbKrdtKWuGisocIdxxgKHXv5B51VjSjfdloKQc0Kpo0hLpaay1uhMrEyxdH8XGMQ2fdGmL1z6Ype-2DjRxd66SZZafUu-4nYAbQHrrsqZNj9v_2P7CfDfj7c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3050755233</pqid></control><display><type>article</type><title>CLIP170 inhibits the metastasis and EMT of papillary thyroid cancer through the TGF-β pathway</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Ma, Binyuan ; Xu, Yaxin ; Gao, Hongwei ; Yang, Yinggui ; Pan, Yunyan ; You, Chongge</creator><creatorcontrib>Ma, Binyuan ; Xu, Yaxin ; Gao, Hongwei ; Yang, Yinggui ; Pan, Yunyan ; You, Chongge</creatorcontrib><description>Metastasis poses a significant challenge in combating tumors. Even in papillary thyroid cancer (PTC), which typically exhibits a favorable prognosis, high recurrence rates are attributed to metastasis. Cytoplasmic linker protein 170 (CLIP170) functions as a classical microtubule plus-end tracking protein (+TIP) and has shown close association with cell migration. Nevertheless, the specific impact of CLIP170 on PTC cells remains to be elucidated. Our analysis of the GEO and TCGA databases unveiled an association between CLIP170 and the progression of PTC. To explore the impact of CLIP170 on PTC cells, we conducted various assays. We evaluated its effects through CCK-8, wound healing assay, and transwell assay after knocking down CLIP170. Additionally, the influence of CLIP170 on the cellular actin structure was examined via immunofluorescence; we further investigated the molecular expressions of epithelial-mesenchymal transition (EMT) and the transforming growth factor-β (TGF-β) signaling pathways through Western blotting and RT-qPCR. These findings were substantiated through an in vivo nude mouse model of lung metastasis. We observed a decreased expression of CLIP170 in PTC in contrast to normal thyroid tissue. Functionally, the knockdown of CLIP170 (CLIP170 KD ) notably enhanced the metastatic potential and EMT of PTC cells, both in vitro and in vivo. Mechanistically, CLIP170 KD triggered the activation of the TGF-β pathway, subsequently promoting tumor cell migration, invasion, and EMT. Remarkably, the TGF-β inhibitor LY2157299 effectively countered TGF-β activity and significantly reversed tumor metastasis and EMT induced by CLIP170 knockdown. In summary, these findings collectively propose CLIP170 as a promising therapeutic target to mitigate metastatic tendencies in PTC.</description><identifier>ISSN: 1559-131X</identifier><identifier>ISSN: 1357-0560</identifier><identifier>EISSN: 1559-131X</identifier><identifier>DOI: 10.1007/s12032-024-02355-z</identifier><identifier>PMID: 38705933</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Animals ; Cell adhesion &amp; migration ; Cell Line, Tumor ; Cell Movement ; Epithelial-Mesenchymal Transition ; Female ; Hematology ; Humans ; Internal Medicine ; Lung Neoplasms - genetics ; Lung Neoplasms - metabolism ; Lung Neoplasms - pathology ; Lung Neoplasms - secondary ; Male ; Medicine ; Medicine &amp; Public Health ; Metastasis ; Mice ; Mice, Nude ; Microtubule-Associated Proteins - genetics ; Microtubule-Associated Proteins - metabolism ; Neoplasm Metastasis ; Neoplasm Proteins - genetics ; Neoplasm Proteins - metabolism ; Oncology ; Original Paper ; Pathology ; Signal Transduction ; Thyroid cancer ; Thyroid Cancer, Papillary - genetics ; Thyroid Cancer, Papillary - metabolism ; Thyroid Cancer, Papillary - pathology ; Thyroid Neoplasms - genetics ; Thyroid Neoplasms - metabolism ; Thyroid Neoplasms - pathology ; Transforming Growth Factor beta - metabolism</subject><ispartof>Medical oncology (Northwood, London, England), 2024-05, Vol.41 (6), p.137, Article 137</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c326t-83ddda9c4b9e340f43ca6d8893482ade681bf950f6c7ae165a4e0ead6006d1423</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12032-024-02355-z$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12032-024-02355-z$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38705933$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ma, Binyuan</creatorcontrib><creatorcontrib>Xu, Yaxin</creatorcontrib><creatorcontrib>Gao, Hongwei</creatorcontrib><creatorcontrib>Yang, Yinggui</creatorcontrib><creatorcontrib>Pan, Yunyan</creatorcontrib><creatorcontrib>You, Chongge</creatorcontrib><title>CLIP170 inhibits the metastasis and EMT of papillary thyroid cancer through the TGF-β pathway</title><title>Medical oncology (Northwood, London, England)</title><addtitle>Med Oncol</addtitle><addtitle>Med Oncol</addtitle><description>Metastasis poses a significant challenge in combating tumors. Even in papillary thyroid cancer (PTC), which typically exhibits a favorable prognosis, high recurrence rates are attributed to metastasis. Cytoplasmic linker protein 170 (CLIP170) functions as a classical microtubule plus-end tracking protein (+TIP) and has shown close association with cell migration. Nevertheless, the specific impact of CLIP170 on PTC cells remains to be elucidated. Our analysis of the GEO and TCGA databases unveiled an association between CLIP170 and the progression of PTC. To explore the impact of CLIP170 on PTC cells, we conducted various assays. We evaluated its effects through CCK-8, wound healing assay, and transwell assay after knocking down CLIP170. Additionally, the influence of CLIP170 on the cellular actin structure was examined via immunofluorescence; we further investigated the molecular expressions of epithelial-mesenchymal transition (EMT) and the transforming growth factor-β (TGF-β) signaling pathways through Western blotting and RT-qPCR. These findings were substantiated through an in vivo nude mouse model of lung metastasis. We observed a decreased expression of CLIP170 in PTC in contrast to normal thyroid tissue. Functionally, the knockdown of CLIP170 (CLIP170 KD ) notably enhanced the metastatic potential and EMT of PTC cells, both in vitro and in vivo. Mechanistically, CLIP170 KD triggered the activation of the TGF-β pathway, subsequently promoting tumor cell migration, invasion, and EMT. Remarkably, the TGF-β inhibitor LY2157299 effectively countered TGF-β activity and significantly reversed tumor metastasis and EMT induced by CLIP170 knockdown. In summary, these findings collectively propose CLIP170 as a promising therapeutic target to mitigate metastatic tendencies in PTC.</description><subject>Animals</subject><subject>Cell adhesion &amp; migration</subject><subject>Cell Line, Tumor</subject><subject>Cell Movement</subject><subject>Epithelial-Mesenchymal Transition</subject><subject>Female</subject><subject>Hematology</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Lung Neoplasms - genetics</subject><subject>Lung Neoplasms - metabolism</subject><subject>Lung Neoplasms - pathology</subject><subject>Lung Neoplasms - secondary</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Metastasis</subject><subject>Mice</subject><subject>Mice, Nude</subject><subject>Microtubule-Associated Proteins - genetics</subject><subject>Microtubule-Associated Proteins - metabolism</subject><subject>Neoplasm Metastasis</subject><subject>Neoplasm Proteins - genetics</subject><subject>Neoplasm Proteins - metabolism</subject><subject>Oncology</subject><subject>Original Paper</subject><subject>Pathology</subject><subject>Signal Transduction</subject><subject>Thyroid cancer</subject><subject>Thyroid Cancer, Papillary - genetics</subject><subject>Thyroid Cancer, Papillary - metabolism</subject><subject>Thyroid Cancer, Papillary - pathology</subject><subject>Thyroid Neoplasms - genetics</subject><subject>Thyroid Neoplasms - metabolism</subject><subject>Thyroid Neoplasms - pathology</subject><subject>Transforming Growth Factor beta - metabolism</subject><issn>1559-131X</issn><issn>1357-0560</issn><issn>1559-131X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtKAzEUhoMotlZfwIUMuHEzenKby1JKWwsVXVRwZchMMp0p7UxNZpD2sXwQn8m0Uy-4EHJIDvn-Pyc_QucYrjFAeGMxAUp8IMwV5dzfHKAu5jz2McXPh7_OHXRi7RyAYE7iY9ShUQg8prSLXvqT8SMOwSvKvEiK2np1rr2lrqV1q7CeLJU3uJ96Veat5KpYLKRZO2ZtqkJ5qSxTbVxrqmaW76TT0dD_eHdsnb_J9Sk6yuTC6rP93kNPw8G0f-dPHkbj_u3ETykJaj-iSikZpyyJNWWQMZrKQEVRTFlEpNJBhJMs5pAFaSg1DrhkGrRUAUCgMCO0h65a35WpXhtta7EsbKrdtKWuGisocIdxxgKHXv5B51VjSjfdloKQc0Kpo0hLpaay1uhMrEyxdH8XGMQ2fdGmL1z6Ype-2DjRxd66SZZafUu-4nYAbQHrrsqZNj9v_2P7CfDfj7c</recordid><startdate>20240505</startdate><enddate>20240505</enddate><creator>Ma, Binyuan</creator><creator>Xu, Yaxin</creator><creator>Gao, Hongwei</creator><creator>Yang, Yinggui</creator><creator>Pan, Yunyan</creator><creator>You, Chongge</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>20240505</creationdate><title>CLIP170 inhibits the metastasis and EMT of papillary thyroid cancer through the TGF-β pathway</title><author>Ma, Binyuan ; Xu, Yaxin ; Gao, Hongwei ; Yang, Yinggui ; Pan, Yunyan ; You, Chongge</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-83ddda9c4b9e340f43ca6d8893482ade681bf950f6c7ae165a4e0ead6006d1423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Animals</topic><topic>Cell adhesion &amp; migration</topic><topic>Cell Line, Tumor</topic><topic>Cell Movement</topic><topic>Epithelial-Mesenchymal Transition</topic><topic>Female</topic><topic>Hematology</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Lung Neoplasms - genetics</topic><topic>Lung Neoplasms - metabolism</topic><topic>Lung Neoplasms - pathology</topic><topic>Lung Neoplasms - secondary</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Metastasis</topic><topic>Mice</topic><topic>Mice, Nude</topic><topic>Microtubule-Associated Proteins - genetics</topic><topic>Microtubule-Associated Proteins - metabolism</topic><topic>Neoplasm Metastasis</topic><topic>Neoplasm Proteins - genetics</topic><topic>Neoplasm Proteins - metabolism</topic><topic>Oncology</topic><topic>Original Paper</topic><topic>Pathology</topic><topic>Signal Transduction</topic><topic>Thyroid cancer</topic><topic>Thyroid Cancer, Papillary - genetics</topic><topic>Thyroid Cancer, Papillary - metabolism</topic><topic>Thyroid Cancer, Papillary - pathology</topic><topic>Thyroid Neoplasms - genetics</topic><topic>Thyroid Neoplasms - metabolism</topic><topic>Thyroid Neoplasms - pathology</topic><topic>Transforming Growth Factor beta - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ma, Binyuan</creatorcontrib><creatorcontrib>Xu, Yaxin</creatorcontrib><creatorcontrib>Gao, Hongwei</creatorcontrib><creatorcontrib>Yang, Yinggui</creatorcontrib><creatorcontrib>Pan, Yunyan</creatorcontrib><creatorcontrib>You, Chongge</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Medical oncology (Northwood, London, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ma, Binyuan</au><au>Xu, Yaxin</au><au>Gao, Hongwei</au><au>Yang, Yinggui</au><au>Pan, Yunyan</au><au>You, Chongge</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CLIP170 inhibits the metastasis and EMT of papillary thyroid cancer through the TGF-β pathway</atitle><jtitle>Medical oncology (Northwood, London, England)</jtitle><stitle>Med Oncol</stitle><addtitle>Med Oncol</addtitle><date>2024-05-05</date><risdate>2024</risdate><volume>41</volume><issue>6</issue><spage>137</spage><pages>137-</pages><artnum>137</artnum><issn>1559-131X</issn><issn>1357-0560</issn><eissn>1559-131X</eissn><abstract>Metastasis poses a significant challenge in combating tumors. Even in papillary thyroid cancer (PTC), which typically exhibits a favorable prognosis, high recurrence rates are attributed to metastasis. Cytoplasmic linker protein 170 (CLIP170) functions as a classical microtubule plus-end tracking protein (+TIP) and has shown close association with cell migration. Nevertheless, the specific impact of CLIP170 on PTC cells remains to be elucidated. Our analysis of the GEO and TCGA databases unveiled an association between CLIP170 and the progression of PTC. To explore the impact of CLIP170 on PTC cells, we conducted various assays. We evaluated its effects through CCK-8, wound healing assay, and transwell assay after knocking down CLIP170. Additionally, the influence of CLIP170 on the cellular actin structure was examined via immunofluorescence; we further investigated the molecular expressions of epithelial-mesenchymal transition (EMT) and the transforming growth factor-β (TGF-β) signaling pathways through Western blotting and RT-qPCR. These findings were substantiated through an in vivo nude mouse model of lung metastasis. We observed a decreased expression of CLIP170 in PTC in contrast to normal thyroid tissue. Functionally, the knockdown of CLIP170 (CLIP170 KD ) notably enhanced the metastatic potential and EMT of PTC cells, both in vitro and in vivo. Mechanistically, CLIP170 KD triggered the activation of the TGF-β pathway, subsequently promoting tumor cell migration, invasion, and EMT. Remarkably, the TGF-β inhibitor LY2157299 effectively countered TGF-β activity and significantly reversed tumor metastasis and EMT induced by CLIP170 knockdown. In summary, these findings collectively propose CLIP170 as a promising therapeutic target to mitigate metastatic tendencies in PTC.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>38705933</pmid><doi>10.1007/s12032-024-02355-z</doi></addata></record>
fulltext fulltext
identifier ISSN: 1559-131X
ispartof Medical oncology (Northwood, London, England), 2024-05, Vol.41 (6), p.137, Article 137
issn 1559-131X
1357-0560
1559-131X
language eng
recordid cdi_proquest_miscellaneous_3051425446
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Animals
Cell adhesion & migration
Cell Line, Tumor
Cell Movement
Epithelial-Mesenchymal Transition
Female
Hematology
Humans
Internal Medicine
Lung Neoplasms - genetics
Lung Neoplasms - metabolism
Lung Neoplasms - pathology
Lung Neoplasms - secondary
Male
Medicine
Medicine & Public Health
Metastasis
Mice
Mice, Nude
Microtubule-Associated Proteins - genetics
Microtubule-Associated Proteins - metabolism
Neoplasm Metastasis
Neoplasm Proteins - genetics
Neoplasm Proteins - metabolism
Oncology
Original Paper
Pathology
Signal Transduction
Thyroid cancer
Thyroid Cancer, Papillary - genetics
Thyroid Cancer, Papillary - metabolism
Thyroid Cancer, Papillary - pathology
Thyroid Neoplasms - genetics
Thyroid Neoplasms - metabolism
Thyroid Neoplasms - pathology
Transforming Growth Factor beta - metabolism
title CLIP170 inhibits the metastasis and EMT of papillary thyroid cancer through the TGF-β pathway
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T11%3A21%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CLIP170%20inhibits%20the%20metastasis%20and%20EMT%20of%20papillary%20thyroid%20cancer%20through%20the%20TGF-%CE%B2%20pathway&rft.jtitle=Medical%20oncology%20(Northwood,%20London,%20England)&rft.au=Ma,%20Binyuan&rft.date=2024-05-05&rft.volume=41&rft.issue=6&rft.spage=137&rft.pages=137-&rft.artnum=137&rft.issn=1559-131X&rft.eissn=1559-131X&rft_id=info:doi/10.1007/s12032-024-02355-z&rft_dat=%3Cproquest_cross%3E3051425446%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3050755233&rft_id=info:pmid/38705933&rfr_iscdi=true